'Breakthrough' Alzheimer's drugs unlikely to benefit patients, report suggests
Influential analysis has concluded that "breakthrough" Alzheimer's drugs are unlikely to benefit patients. Researchers said the impact was "well below" what was needed to make a difference to dementia patients' lives. However, their report has also provoked a …






























